Advertisements



Medtronic initiates clinical study to assess safety of drug-eluting stents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

UAB will take part in global clinical trial for COVID-19 treatment

UAB will take part in a National Institutes of Health (NIH)-sponsored global clinical trial to evaluate the safety and efficacy of therapeutic agents in hospitalized adult patients who have been diagnosed with COVID-19 (coronavirus).  The drug remd.....»»

Category: topSource: bizjournalsMar 26th, 2020

Acceleron Pharma stock soars more than 50% on hypertension drug study

Acceleron Pharma Inc. shares surged in the extended session late Monday after the biotech drug maker said its hypertension drug hit key goals in a mid-stage clinical trial. Acceleron shares soared 56%.....»»

Category: topSource: marketwatchJan 27th, 2020

Merck stock slides as lung-cancer drug misses a study endpoint

Merck & Co. shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0......»»

Category: topSource: marketwatchJan 6th, 2020

Mesoblast Submits Clinical Efficacy and Safety Data to FDA in Rolling Biologics License Application for Remestemcel-l

Mesoblast Limited (Nasdaq: MESO) announced that the United States Food and Drug Administration (US FDA) has confirmed receipt of Mesoblast's .....»»

Category: blogSource: benzingaJan 1st, 2020

vTv Therapeutics to complete Phase 2 of Alzheimer’s study by 2021

vTv Therapeutics (NSDQ:VTVT), the High Point biopharmaceutical company, expects to complete Phase 2 of its Alzheimer’s disease study by 2021.  The clinical trial for azeliragon, a drug created by the company to slow or halt the progression of t.....»»

Category: topSource: bizjournalsDec 19th, 2019

Fate Therapeutics" stock rises on early-stage cancer drug data

Shares of Fate Therapeutics gained 37% after it shared promising data from one clinical and one preclinical study for its experimental cancer immunotherapy treatments. The company is testing two therapies, FT516 and FT500, in.....»»

Category: topSource: marketwatchDec 9th, 2019

CymaBay Halts Study On Lead Clinical Program, Stock Crashes

CymaBay Therapeutics Inc (NASDAQ: CBAY) shares are losing more than 75% of their value Monday after the company said it's halting the development of its lead drug, seladelpar. 0 read more.....»»

Category: blogSource: benzingaNov 25th, 2019

NeuroVive Pharmaceutical AB Interim Report January - September 2019

STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events July - September NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study NeuroSTAT r.....»»

Category: earningsSource: benzingaNov 20th, 2019

Turning Point Therapeutics initiates Phase 1/2 clinical study of repotrectinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019

Turning Point Therapeutics initiates Phase 1/2 clinical study of TPX-0046

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 11th, 2019

Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial

Merck KGaA and Pfizer said Friday that a late-stage clinical trial testing Bavencio as a first-line maintenance treatment for patients with certain forms of gastric cancer failed to meet the study's primary endpoints for survival. The cur.....»»

Category: topSource: marketwatchNov 8th, 2019

Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side Effects

Tilray, Inc. (NASDAQ: TLRY) announced Thursday it has imported medical cannabis into the U.S. from Canada to back a new clinical trial. read more.....»»

Category: blogSource: benzingaOct 24th, 2019

Zosano Pharma initiates Phase 2/3 clinical study in cluster headache

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2019

Nektar initiates Phase 1 clinical study of NKTR-255 candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2019

Medtronic initiates worldwide study of EV ICD system for fast heart rhythms

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 7th, 2019

Cassava Sciences initiates Phase 2b clinical study of PTI-125 in Alzheimer"s

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 16th, 2019

Acadia Stops Nuplazid Study Early After Drug Shows "Statistically Superior Efficacy" In Dementia-Related Psychosis

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares are soaring to their highest level in about two years following a clinical trial readout from the company. read more.....»»

Category: blogSource: benzingaSep 9th, 2019

Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress

- Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemph.....»»

Category: earningsSource: benzingaAug 29th, 2019

AstraZeneca"s Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage Study

AstraZeneca plc (NYSE: AZN) faced a clinical setback in a study evaluating a combo drug regimen in non-small cell lung cancer, or NSCLC. read more.....»»

Category: blogSource: benzingaAug 21st, 2019

PAVmed completes clinical safety study procedures for CarpX 510 resubmission

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2019